PUBLISHER: Grand View Research | PRODUCT CODE: 1654502
PUBLISHER: Grand View Research | PRODUCT CODE: 1654502
The global antimicrobial plastic market size is estimated to reach USD 73,769.24 million by 2030, expanding at a CAGR of 7.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing demand for products from packaging, health care, consumer products, and some other industries is expected to drive the market. Moreover, the growing complex epidemiological situations, such as COVID-19, microbial contamination, hospital-acquired infections, and healthcare-associated infections (HCAIs), are expected to fuel the growth of the market.
The healthcare segment has shown high penetration rates and it accounted for the majority of revenue share in 2021. This can be explained by the strong demand for antimicrobial plastics for the production of sterilized and infection-preventing products such as surgical cables, tubes, and orthopedic sutures. In addition, growing consumer health awareness, an increase in the elderly population in countries such as Japan, China, and the United States, and growing demand for high-quality medical equipment are expected to drive the market.
Companies in the market compete based on the quality of the products they offer and the technology used to produce antimicrobial plastics. Major players are engaging in mergers and acquisitions, expanding their manufacturing capacity, developing infrastructure, investing in R&D centers, and looking for vertical integration opportunities along the entire value chain. These initiatives help them meet growing global demand, stay competitive, improve sales and operations planning, develop innovative products and technologies, reduce manufacturing costs, and expand their customer base.
In February 2021, Sanitized AG introduced a new product to its existing BroadTect portfolio. This product provides protection to polymers against a wide range of microorganisms including gram-positive and gram-negative bacteria, mold and mildew, yeasts, and algae. It has higher temperature resistance and is suitable for thermoplastic processing methods such as extrusion and injection molding and thermoplastic polymers such as polyethylene (PE), polypropylene (PP), thermoplastic polyurethane (TPU), ethylene-vinyl acetate (EVA), polyvinyl chloride (PVC), and rubber.
Similarly, in March 2020, Covalon Technologies Ltd. formulated a new antimicrobial technology "CovaGuard" to kill coronavirus and other viruses and pathogens present on the surface of the polymers by using active antiviral and antimicrobial agents. This technology is capable of trapping, deactivating, and killing viruses over an extended period. This new technology will help in reducing the spread of coronavirus; protecting first responders, healthcare workers, and patients; and strengthening the company's position in the healthcare industry.